| Advanced Interventional Pain And Wellness Center Inc | |
|
6700 Indiana Ave Suite 145 Riverside CA 92506-4290 | |
| (951) 248-9240 | |
| (951) 248-9263 |
| Full Name | Advanced Interventional Pain And Wellness Center Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 6700 Indiana Ave, Riverside, California |
| Authorized Official Name and Position | Larry Gilbert Ding (MEDICAL DIRECTOR) |
| Authorized Official Contact | 9494441886 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Advanced Interventional Pain And Wellness Center Inc 218 Avenida La Cuesta San Clemente CA 92672-2139 Ph: (949) 444-1885 | Advanced Interventional Pain And Wellness Center Inc 6700 Indiana Ave Suite 145 Riverside CA 92506-4290 Ph: (951) 248-9240 |
| NPI Number | 1053568030 |
|---|---|
| Provider Enumeration Date | 08/21/2008 |
| Last Update Date | 04/13/2017 |
| Medicare PECOS PAC ID | 4183788193 |
|---|---|
| Medicare Enrollment ID | O20090205000147 |
News Archive
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
A newly discovered interplay of cells in one of the brain's memory centers sheds light on how you recall your grocery list, where you laid your keys, and a host of important but fleeting daily tasks.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053568030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Secondary |
| 261QM2500X | Clinic/center - Medical Specialty | A66008 (California) | Primary |
| Provider Name | Larry G Ding |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1750325643 PECOS PAC ID: 7214833011 Enrollment ID: I20090205000143 |
News Archive
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
A newly discovered interplay of cells in one of the brain's memory centers sheds light on how you recall your grocery list, where you laid your keys, and a host of important but fleeting daily tasks.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.
› Verified 6 days ago
News Archive
The job of implementing a key Obama administration health reform -;a statewide marketplace where consumers and businesses can buy affordable health insurance-;would be turned over to a non-profit company under proposed legislation announced today by Michigan's Republican Gov. Rick Snyder.
A newly discovered interplay of cells in one of the brain's memory centers sheds light on how you recall your grocery list, where you laid your keys, and a host of important but fleeting daily tasks.
Scientists have determined the detailed structure of an essential piece of the telomerase enzyme, an important contributor to the vast majority of human cancers. Understanding the physical shape of the protein has led to a better understanding of how it acts to immortalize cells - and should help scientists design broadly effective cancer drugs.
Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.
Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.
› Verified 6 days ago
Innovative Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4500 Brockton Ave Ste 305, Riverside, CA 92501 Phone: 206-445-9978 Fax: 858-280-3279 | |
Pulmonary Partners Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5790 Magnolia Ave, Suite 201, Riverside, CA 92506 Phone: 951-368-0427 Fax: 951-368-0429 | |
Lyn M Pintelon D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8990 Garfield St, Ste.6, Riverside, CA 92503 Phone: 951-358-0784 Fax: 951-354-7583 | |
Precision Spinal Care Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4224 Cedar Pine Ct, Riverside, CA 92505 Phone: 909-648-0377 | |
Parkview Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3722 Tibbetts St, Riverside, CA 92506 Phone: 951-784-3770 | |
Orangecrest Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4646 Brockton Ave Ste 203, Riverside, CA 92506 Phone: 951-774-2881 Fax: 951-774-2846 | |
Harmony Health Solutions Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5750 Division St Ste 208, Riverside, CA 92506 Phone: 310-560-9292 |